FormWeb • tolnaftate topical

Oregon Department of Corrections

Approved Formulary

Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions

Webpage Links

Add Formweb to your mobile device

Android iOS

February P&T meeting minutes have been posted.

Oregon Department of Corrections

Approved Formulary

Search results for:

tolnaftate topical

tolnaftate topical

Formulary Duration Restrictions Limited to 4 months without TLC approval.
Cell Status Approved (cream); NFISA (powder)
Exceptions / Designators Cream only. Powder remains non-formulary due to flammability.

Brand names: TINACTIN, Tolnaftate

Form	Strength
CREAM, TOPICAL	1%

Additional Information:

AUGUST 2021 P&T MINUTES

MARCH 2014 P&T MINUTES

Last updated: Sep. 13, 2021

UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier

This site is intended for the staff of Oregon Department of Corrections.
While others may view accessible pages, Oregon Department of Corrections makes no warranty, express or implied,
as to the use of this information outside of Oregon Department of Corrections.